GLP-1 Online: The 9 Telehealth Providers Worth Knowing in 2026

Buying a GLP-1 online in 2023 meant choosing between Ro, a few startups, and a long tail of compounding-pharmacy services that filled prescriptions in 48 hours for cash. The market in 2026 looks completely different. The FDA cleared tirzepatide off the shortage list in December 2024 and semaglutide in February 2025, ending the legal cover that powered mass compounding. On September 16, 2025 the FDA sent warning letters to more than 55 telehealth companies for illegally marketing compounded GLP-1s. On March 9, 2026, Hims settled with Novo Nordisk, dropped compounded semaglutide, and became a paid telehealth channel for branded Wegovy. The result: a smaller, more split, and frankly more honest market.

Before you start, it helps to know what to expect from GLP-1 therapy.

Every telehealth platform listed below sells one of the same handful of weight loss injections — what differs is the price, the prescribing model, and whether you get branded product or a compounded alternative.

Direct answer: As of May 2026, GLP-1 telehealth options split into two camps. The branded-only group — Ro ($149/month membership), Hims ($149/month), WeightWatchers Clinic ($74–$149/month), Calibrate (~$199/month), and Form ($179/month) — sells FDA-approved Wegovy ($199–$349/month), Zepbound ($299–$549/month), oral Wegovy ($149–$299/month, NovoCare), and Foundayo, runs prior-authorization workflows, and connects manufacturer savings cards that drop insured medication cost to $0–$25/month. The compounded-focused group — Henry Meds ($197–$449/month bundled), Mochi ($178/month total), Eden ($149–$196/month), and Shed (variable) — sells 503A-compounded semaglutide or tirzepatide cash, no insurance involved. Cheapest is rarely the best clinical fit, and the compounded group now operates under documented-medical-necessity rules rather than the old shortage exemption.

How to Get a GLP-1 Online, Step by Step

You need a prescription from a licensed clinician, which a telehealth service can write after an online intake, and then the drug ships to you from a pharmacy. If you already have a prescriber, you can also skip the telehealth membership and buy branded Wegovy or Zepbound straight from the manufacturer's pharmacy.

1. Check you fit the label. Adults: BMI 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol or sleep apnea. These are the populations in the trials behind the Zepbound label (Zepbound label, DailyMed); the Wegovy label indications cover adults with obesity, or overweight plus a weight-related comorbid condition (Wegovy label, DailyMed). Teens are covered in the teens section below.
2. Pick a route. A telehealth platform (tables below), your own doctor, or a manufacturer pharmacy that fills a prescription from any licensed prescriber.
3. Complete the intake. Health history, current medications, weight (often a photo or scale reading), sometimes labs. A personal or family history of medullary thyroid carcinoma or MEN 2 rules these drugs out (boxed warning on both labels above).
4. Sort out payment. Insurance with prior authorization, or self-pay. See GLP-1 insurance coverage.
5. Medication ships; follow-ups continue through dose increases.

For the prescription side in more detail, see how to get a GLP-1 prescription.

GLP-1 Medications You Can Get Online

These are the FDA-approved GLP-1 weight-loss drugs that telehealth services and manufacturer pharmacies dispense, with the manufacturer's own cash price (telehealth membership fees are extra).

Ozempic and Mounjaro are type 2 diabetes drugs; online weight-loss services that prescribe them for weight loss are using them off-label. Compounded semaglutide and tirzepatide are also sold online, but FDA says compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before they are marketed (FDA). See compounded semaglutide for the details.

What Changed in 2024-2026

The compounded GLP-1 market is a fraction of what it was 18 months ago. A condensed timeline:

The legal framework matters. Compounded GLP-1s are now sold only under 503A pharmacy compounding rules — each prescription must document a specific clinical need (dose unavailable commercially, allergy to an excipient, etc.) rather than ride a blanket shortage exemption. Mass compounding for general weight loss is the basis of the FDA letters.

SkinnyRx

GLP-1 weight loss, prescribed online

Compounded or FDA-approved GLP-1s,
with clinician-guided care.

Complete an online intake and a licensed provider reviews it. FDA-approved options, including Wegovy and Foundayo, are available through the SkinnyRx Membership.

See if you qualify

Semaglutide and tirzepatide · injections or tablets

Prescription required; a licensed provider decides whether treatment is appropriate. Compounded drugs are not FDA-approved or evaluated for safety, effectiveness or quality by the FDA. We may earn a commission.

The 9 Telehealth Providers Worth Comparing

Branded-Only Providers

These charge a membership fee on top of the medication and run insurance benefit checks. Best for patients with commercial coverage or for self-pay patients who want full-label drugs.

Compounded-Focused Providers

These bundle medication, provider visit, and shipping into one cash price. No insurance billing. All-in pricing is generally cheaper than branded self-pay, but with the trade-offs of compounded medication.

Real Out-of-Pocket Cost Scenarios

The advertised price almost never matches the wallet hit. Three realistic scenarios:

Scenario A: Commercial Insurance + Branded GLP-1

• Provider membership: $74-$199/month
• Wegovy or Zepbound after insurance + manufacturer savings card: $0-$25/month
• Total typical: $74-$224/month

This is the cheapest path if your plan covers obesity medication. Ro, Hims, and WeightWatchers Clinic each run prior-authorization workflows.

Scenario B: Self-Pay Branded

• Provider membership: $74-$199/month
• Wegovy: $199-$349/month; oral Wegovy: $149-$299/month; Zepbound: $299-$549/month
• Total typical: $273-$748/month

This is the option for patients without obesity coverage who still want full-label medication. Cash pricing has come down: Wegovy starter pens are $199/month, and oral Wegovy is $149/month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg through Novo's NovoCare cash channel (NovoCare), and WeightWatchers Med+ also sells it.

Scenario C: Self-Pay Compounded

• All-in (medication + visit + shipping): $149-$329/month, generally
• Higher tirzepatide doses can push Henry Meds to $449/month

Often the cheapest path overall, but with the regulatory and quality uncertainties that came into sharper focus after the September 2025 FDA enforcement wave.

Branded vs Compounded: The Decision That Matters Most

The FDA was explicit in its September 2025 announcement. The agency cited telehealth marketing that "falsely suggests compounded GLP-1s are identical to approved products and misrepresents sourcing, reinforcing that compounded drugs bypass FDA premarket safety, efficacy, and quality review." That language matters because it tells you what the regulator views as misleading — claims of identity with the branded drug, claims about pharmaceutical-grade sourcing, claims about FDA equivalence. None of those claims hold up.

The compounded product can still be a reasonable choice for an uninsured patient who would otherwise not get treatment. It is not a reasonable choice for a patient who can get the branded version for $25/month with insurance.

Provider Deep Dives

Ro

The polished default for branded GLP-1. Membership is $39 the first month, then $74/month on annual prepay or $149/month on a month-to-month plan. Wegovy pens are $199/month for the first two months and $349/month thereafter when self-pay; Zepbound is $299-$449/month depending on dose. Ro's main advantage is its insurance concierge team, which runs prior authorization paperwork and applies Novo and Lilly savings cards. For insured patients this turns a $500+ medication bill into a $0-$25 copay. For self-pay, Ro is similar in cost to going through any clinic.

Hims

Was the largest compounded-semaglutide seller in 2024-2025. After the March 9, 2026 Novo settlement, Hims stopped advertising compounded GLP-1 and became an authorized telehealth channel for branded Wegovy, oral Wegovy, Ozempic, and Zepbound. Membership is $39 the first month, $149/month after that. Wegovy and Ozempic are priced at "telehealth-standard" rates per the settlement. Existing compounded patients are being transitioned through mid-2026. Hims has no video consultations, no required labs, and no obesity-medicine specialists — clinical interaction is text-only.

WeightWatchers Clinic (formerly Sequence)

WW acquired Sequence for $132 million in 2023 and rebranded it as WW Clinic. The introductory pricing is the lowest on the branded side: $25 for the first month on a 12-month plan, then $74/month for the rest of the year. Month-to-month is $149/month. Through August 31, 2026, oral Wegovy 1.5-4 mg is $149/month through WW Med+ for eligible self-pay patients. Self-pay Wegovy and Ozempic pens are $199/month introductory through March 31, 2026, then $349/month. The care team handles insurance PA. The best fit for patients who want structured behavioral support alongside medication.

Calibrate

Twelve-month metabolic-reset program at roughly $199/month on annual prepay. Heavier emphasis on coaching and lifestyle integration than the strictly transactional services. Branded only. Best for patients who want a full-program structure rather than a pure prescription service.

Form

Smaller, physician-led, branded only. $179/month membership. Marketed on the strength of its prescribing clinicians — board-certified in obesity medicine — which is unusual in this category. Best for patients who want a higher clinical bar without paying boutique-clinic prices.

Henry Meds

Has avoided FDA warning letters so far. All-in pricing is the marketing hook: provider visit, supplies, and shipping bundled into one monthly fee. Real prices are higher than the homepage suggests — the advertised "$179/month" is for liraglutide or a 12-month prepay on injectable semaglutide. Standard month-to-month compounded semaglutide injection is $297/month (or $247 first month), oral semaglutide is $249/month, injectable tirzepatide is $449/month, and oral tirzepatide is $349/month. No labs required at intake.

Mochi Health

Flat-rate compounded pricing — $99/month for compounded semaglutide injection regardless of dose, plus a $79/month membership for a $178/month total. Tirzepatide is $199/month flat. Strengths include video consultations with board-certified obesity medicine physicians and the widest medication selection in the compounded space (semaglutide as injection, oral tablet, oral drops, and microdose). Concerns include an active Eli Lilly lawsuit over compounded tirzepatide marketing and a 2025 pharmacy partner that was shut down for unsafe compounding practices.

Eden

Flat upfront pricing that does not change with dose. $149-$196/month for compounded products. Also lists brand-name medications (Mounjaro, Ozempic, Victoza, Wegovy, Zepbound). Eden's self-reported member data shows an average of 29.3 lbs lost in 6 months across 111 members — directionally consistent with clinical trial averages.

Shed

A newer entrant pitching brand-name plus compounded under one program with a weight-loss guarantee. Reviewer ratings are favorable but the model is unverified at scale. Compounded options still lack FDA premarket approval; cash-pay only; state coverage varies.

Best Site for GLP-1: It Depends on How You Pay

There is no single best site for GLP-1. The best one is the one that matches your insurance, whether you want branded or compounded medication, and how much clinical contact you want.

"Best" should also mean the site actually evaluates you. A 2026 secret-shopper study in JAMA tested 49 online GLP-1 sellers between August and December 2025: 45 issued a prescription and 34 mailed the drug, but only 13 required a video visit and 3 a phone call (Chetty et al., JAMA 2026; counts as reported by Pharmacy Times). See the Quality Signals That Matter section below for what to check.

A Reasonable Decision Tree

Step 1: Do you have commercial insurance with obesity coverage?

• Yes → WeightWatchers Clinic, Ro, or Hims. Their PA teams get most insured patients to $0-$25 medication + a $74-$149 membership.
• No → continue to Step 2.

Step 2: Can you afford $300-$500/month for branded medication?

• Yes → Ro Wegovy at $199 starter, or oral Wegovy at $149/month through Med+. Predictable supply, full label.
• No → continue to Step 3.

Step 3: Are you willing to use a 503A-compounded GLP-1?

• Yes → Mochi ($178 total) or Eden ($149-$196) are the cheapest with decent quality signals. Henry Meds is more expensive month to month but established.
• No → look at manufacturer cash programs (NovoCare, LillyDirect Zepbound vials) which now overlap compounded pricing for low doses.

Quality Signals That Matter

Things to verify before signing up with any provider:

• A licensed clinician evaluates you — not just a form review by an algorithm
• Labs ordered before the first prescription — the gold standard, especially for patients with thyroid, kidney, or pancreatic history
• Pharmacy name is shared — branded: standard retail. Compounded: ask for the pharmacy and the state. State board action against the pharmacy in the last 24 months is a red flag.
• Video or phone access during titration — text-only support is normal but limiting when nausea spikes at week 4
• Discontinuation policy is reasonable — patients are not flight risks. Look for clean cancel flows.
• Membership renewal is transparent — most auto-renew; set a calendar reminder when you sign up
• Return policy on medication — compounded medication is generally not returnable; budget accordingly

Red Flags

• "Limited slots" or countdown timers
• No labs requested, even when you offer to provide them
• One-size-fits-all dosing protocols with no clinician input
• Communication via unencrypted SMS only
• Pharmacy name not disclosed before purchase
• Prescriber credentials not disclosed
• Prescription written within minutes of a questionnaire submission
• Auto-renew that requires phone calls to cancel
• Marketing that claims the compounded product is "identical to" or "the same as" brand-name Wegovy or Zepbound — that is the exact language the FDA cited in its September 2025 warning letters

What Telehealth Cannot Do Well

• Complex medical histories — prior pancreatitis, heart failure, advanced CKD, or thyroid history needs an in-person specialist
• Children and teens — most platforms exclude under-18s
• Pregnancy planning — semaglutide and tirzepatide need a 2-month washout before conception. Better managed by a coordinated team.
• Polypharmacy with many interactions — coordination is hard when the GLP-1 prescriber never sees your other meds
• Patients on Medicare — the membership fee is wasted money for most Medicare beneficiaries who have a covered provider

GLP-1 for Teens Online: What's Approved and Who Treats Minors

Two GLP-1 drugs are FDA-approved for weight management in teens: Wegovy injection and Saxenda, both from age 12. Most adult telehealth platforms will not treat anyone under 18, so teens usually go through a pediatrician or a pediatric telehealth program instead.

• Wegovy injection: approved for pediatric patients aged 12 years and older with obesity, which in this age group means a BMI at or above the 95th percentile for age and sex. The label notes a 1.7 mg weekly maintenance dose is also supported in pediatric patients (Wegovy label, DailyMed).
• Saxenda (liraglutide): approved for teens 12+ with body weight over 60 kg and an initial BMI corresponding to 30 or more for adults by international cut-offs. The label says to stop it if BMI hasn't fallen by at least 1% after 12 weeks on the maintenance dose (Saxenda label, DailyMed).
• Not approved for teens: Zepbound, Wegovy tablets and Foundayo. Their labels say safety and effectiveness have not been established in pediatric patients, or that it is not known if they are safe and effective in children (Zepbound label, Foundayo label).
• Ro: the weight-loss program is for adults 18 and up (Ro Terms of Use).
• Hims & Hers: terms require users to be 18 or older, and the only under-18 exception is acne consultations for 13 to 17-year-olds with parental consent, so weight loss is adults-only (Hims terms).
• Henry Meds: GLP-1 programs require patients to be at least 18 and no older than 80 (Henry Meds GLP-1).
• Mochi Health: the exception among the providers in this guide. Its FAQ says it offers a Pediatrics program for patients under 18, with eligibility checked by form (Mochi FAQ). The FAQ does not say which drugs it uses for minors, so ask whether the plan is branded Wegovy or Saxenda.
• Pediatric-only telehealth: some practices treat only minors. One example is Blueberry Pediatrics' Blueberry Balance, a virtual program for ages 12 to 17 that prescribes branded Wegovy and does not use compounded GLP-1s (Blueberry Pediatrics).

The evidence is for the branded drugs. In STEP TEENS (201 adolescents aged 12 to under 18, semaglutide 2.4 mg weekly, 68 weeks, Novo Nordisk funded), BMI fell 16.1% with semaglutide versus a 0.6% rise with placebo; 73% vs 18% lost at least 5% of body weight; gallstones occurred in 4% on semaglutide vs none on placebo (Weghuber et al., NEJM 2022). That 16.1% is BMI change, not body-weight loss. The American Academy of Pediatrics' 2023 obesity guideline says pediatricians should offer weight-loss medication to adolescents 12 and older with obesity, as an add-on to health behavior and lifestyle treatment, not a replacement (AAP guideline, Pediatrics 2023).

Avoid compounded GLP-1s for teens: they are not FDA-approved (FDA), and the trial and labels cover only the branded drugs. On cost, NovoCare's Wegovy savings sign-up requires the primary adult contact to be 18 or older, so a parent enrolls (NovoCare). Start with the teen's pediatrician, who can prescribe either drug and coordinate the lifestyle program the guideline calls for.

What People Get Wrong About Online GLP-1

• "Compounded telehealth GLP-1 is the same drug as the pharmacy version." It is not. Compounded semaglutide is a legally distinct formulation made by a 503A pharmacy. The FDA has been explicit that this claim is misleading.
• "The shortage is back, so compounding is legal again." It is not. FDA cleared both shortages and the grace period ended in May 2025. Compounding now requires documented patient-specific need.
• "Hims still sells $49 compounded sema." Not since March 9, 2026. The settlement with Novo Nordisk ended that.
• "All telehealth providers are basically equivalent." Pricing, clinical depth, supply chain, and regulatory exposure vary widely.
• "I can just stop paying and the membership will go away." Auto-renew is the norm. Cancel explicitly through the dashboard.
• "Cheaper is always better." A $99 compounded plan with no labs and no after-hours support can be worse than a $200 branded plan with proper care.

Frequently Asked Questions

Can I get a GLP-1 prescription entirely online in 2026? Yes. Major telehealth platforms (Ro, Hims, WeightWatchers Clinic, Calibrate, Form) write prescriptions for branded Wegovy, Zepbound, oral Wegovy, and Foundayo. Compounded providers (Henry Meds, Mochi, Eden, Shed) write prescriptions for 503A-compounded semaglutide or tirzepatide. State availability varies.

Is online GLP-1 cheaper than going to a doctor in person? Not always. With commercial insurance and a savings card, your primary care doctor can usually get you the same $0-$25 medication price without a $149 membership fee. Telehealth wins on speed and on bundled compounded pricing for self-pay patients.

Are compounded GLP-1s still available online after FDA cleared the shortages? Yes, but under stricter rules. The mass-compounding exemption ended in May 2025. 503A pharmacy compounding now requires a documented patient-specific medical need — e.g., a dose not commercially available or a documented allergy to an excipient — rather than a blanket shortage justification.

Which telehealth provider has the cheapest GLP-1? For insured patients: WeightWatchers Clinic ($25 first-month membership intro). For self-pay compounded: Mochi at $178/month all-in. For self-pay branded: Novo's NovoCare cash pricing or Ro's $199 Wegovy starter.

Does insurance cover online GLP-1 prescriptions? For branded medications, yes — about 50-60% of commercial plans cover Wegovy or Zepbound for obesity, with prior authorization. Compounded GLP-1s are almost never covered.

Is it safe to buy GLP-1 from a telehealth provider? The reputable end of the market — providers with licensed clinicians, identifiable pharmacies, and proper screening — is safe. The risky end is the providers that received FDA warning letters in September 2025 and the ones that continue to make claims of identity with branded drugs.

Did Hims really exit compounded GLP-1? For new patients, yes, as of March 9, 2026. Existing patients are being transitioned to branded products through mid-2026 under the settlement terms with Novo Nordisk.

What is the difference between Sequence and WeightWatchers Clinic? Same thing. WW acquired Sequence in 2023 and rebranded the service as WW Clinic. The joinsequence.com domain redirects to the WeightWatchers clinic page.

Can I cancel my GLP-1 telehealth membership easily? Most providers allow cancellation through the account dashboard, but auto-renew is universal. Cancel explicitly, save the confirmation email, and watch your next statement.

Can teenagers get a GLP-1 online? Sometimes. Wegovy injection and Saxenda are FDA-approved from age 12 (Wegovy label, Saxenda label), but Ro, Hims and Henry Meds treat adults only. Mochi has a pediatrics program, and pediatric telehealth programs or the teen's own pediatrician are the usual route. Zepbound, Wegovy tablets and Foundayo are adults-only.

What is the best site to get a GLP-1 online? There is no single best site. With obesity coverage, pick a service with a prior-authorization team such as WeightWatchers Clinic or Ro. Self-pay with your own prescriber, use a manufacturer pharmacy (NovoCare Pharmacy, LillyDirect), which has no membership fee. Choose one where a clinician actually reviews you: in the 2026 JAMA secret-shopper study only 13 of 49 sellers required a video visit (JAMA).

Can I buy Wegovy or Zepbound online without a telehealth membership? Yes, if a licensed clinician prescribes it. NovoCare Pharmacy sells Wegovy pens from $199/month for the first two fills of the starter doses (through Dec 31, 2026), then $349 (NovoCare); LillyDirect sells Zepbound from $299/month for 2.5 mg (LillyDirect).

Last reviewed: May 13, 2026

Sources

• FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s — FDA
• FDA Ramps Up Crackdown on GLP-1 Drug Compounding with Fresh Batch of 30 Warning Letters — Fierce Pharma
• FDA and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown — Pharmacy Times
• From Crackdown to Collaboration: FDA Warning Letters and the Hims-Novo Nordisk Deal — Frier Levitt
• Hims & Hers Shares Surge After Novo Nordisk Drops Patent Case — CNBC
• Novo Nordisk Drops Patent Suit as Hims & Hers Shifts to FDA-Approved Semaglutide — HMP Global
• Weight Loss Program Pricing — Ro
• Medical Weight-Loss Clinic Pricing & Plans — WeightWatchers Clinic
• Henry Meds Review 2026: Options & Pricing — ManyTreatments
• Mochi Health GLP-1 Review: The Real Cost in 2026 — Nutrition and Nourishment Collective
• Eden GLP-1 Review 2026: Pricing, Medications & Is It Worth It? — GLP1 Clinics
• 15 Top GLP-1 Weight Loss Medication Providers in 2026 — U.S. News
• Cheapest Online GLP-1 Programs That Won't Break the Bank — Vaccine Alliance
• Hims GLP-1 2026: Complete Guide to Pricing, Medications, Novo Partnership — Telehealth Ally
• Wegovy (semaglutide) Prescribing Information — DailyMed
• Saxenda (liraglutide) Prescribing Information — DailyMed
• Zepbound (tirzepatide) Prescribing Information — DailyMed
• Foundayo (orforglipron) Prescribing Information — DailyMed
• Once-Weekly Semaglutide in Adolescents with Obesity (STEP TEENS) — NEJM / PubMed
• Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity — AAP, Pediatrics
• Online Prescribing of GLP-1 Receptor Agonists — JAMA
• Online GLP-1 Sellers Often Skip Clinician Oversight, Secret Shopper Study Finds — Pharmacy Times
• Wegovy Self-Pay Savings Offer — NovoCare
• Zepbound Through LillyDirect — Eli Lilly
• Foundayo Savings & Coverage — Eli Lilly
• FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — FDA